Analgesics in the UK

Publication Date	March 2006
Publisher	Euromonitor
Product Type	Report
Pages	46
ISBN Number	not applicable
Product Code	EUR00686

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This Analgesics in the UK report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (19992004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: adult analgesics, childspecific analgesics, systemic analgesics, topical analgesics Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the analgesics industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use fiveyear forecasts to assess how the market is predicted to develop

Content

1. Executive Summary
2. Operating Environment
- 2.1 Otc Registration and Classification
- 2.2 Vitamins & Dietary Supplements Registration and Classification
- 2.3 Advertising
- 2.4 Packaging and Labelling
- 2.5 Distribution
- 2.6 DeListing or DeReimbursement
- 2.7 Traditional Remedies
- 2.8 Homeopathy
- 2.9 Generics
- 2.10 Consumer Expenditure on Health Goods and Medical Services
- 2.11 Life Expectancy
3. Otc Healthcare Sales
- 3.1 Market Performance
- 3.2 Switches
- 3.3 Key Trends and Developments
- 3.4 Competitive Environment
- 3.5 Leading Company Profiles Bayer Plc
- 3.6 Leading Company Profiles Boots Healthcare International
- 3.7 Leading Company Profiles Glaxosmithkline Plc
- 3.8 Leading Company Profiles Johnson & Johnson Msd Ltd
- 3.9 Leading Company Profiles Novartis Pharmaceuticals UK Ltd
- 3.10 Leading Company Profiles Pfizer Consumer Healthcare Ltd
- 3.11 Leading Company Profiles Reckitt Benckiser Plc
- 3.12 Leading Company Profiles Roche Products Ltd
- 3.13 Leading Company Profiles Seven Seas Ltd
- 3.14 Leading Company Profiles Ssl International Plc
- 3.15 Leading Company Profiles Wyeth Consumer Healthcare
- 3.16 Emerging and Niche Companies
- 3.17 Retail Distribution
- 3.18 Retailer Activity and Private Label Trends
- 3.19 Forecast Market Performance
4. Analgesics Sales
- 4.1 Sector Performance
- 4.2 New Product Developments
- 4.3 Analgesics by Herbal/Standard Split
5. Other Otc
6.Definitions
List of Summaries
- Summary 1 Otc Healthcare Switches 20042005
- Summary 2 Bayer Ag Operational Indicators 2004
- Summary 3 Boots Healthcare International Operational Indicators 2005
- Summary 4 Glaxosmithkline Operational Indicators 2004
- Summary 5 Johnson & Johnson Inc Operational Indicators 2004
- Summary 6 Novartis Ag Operational Indicators 2004
- Summary 7 Pfizer Inc Operational Indicators 2004
- Summary 8 Reckitt Benckiser UK Ltd Operational Indicators 2004
- Summary 9 Roche Holding Ag Operational Indicators 2004
- Summary 10 Wyeth Consumer Healthcare Operational Indicators 2004
- Summary 11 Analgesics: New Product Launches 20032004
List of Tables
- Table 1 Retail Sales of Homoeopathy 19982003
- Table 2 Consumer Expenditure on Health Goods and Medical Services 19992004
- Table 3 Life Expectancy at Birth 19992004
- Table 4 Sales of Otc Healthcare by Sector: Value 19992004
- Table 5 Sales of Otc Healthcare by Sector: % Value Growth 19992004
- Table 6 Otc Healthcare Company Shares 20012004
- Table 7 Otc Healthcare Brand Shares 20012004
- Table 8 Bayer Plc Shares of Otc Healthcare by Subsector 20012004
- Table 9 Crookes Healthcare Ltd Shares of Otc Healthcare by Subsector 20012004
- Table 10 Boots Plc Shares of Otc Healthcare by Subsector 20012004
- Table 11 Glaxosmithkline Plc Shares of Otc Healthcare by Subsector 20012004
- Table 12 Johnson & Johnson Msd Ltd Shares of Otc Healthcare by Subsector 20012004
- Table 13 Novartis Pharmaceuticals UK Ltd Shares of Otc Healthcare by Subsector 20012004
- Table 14 Pfizer Consumer Healthcare Ltd Shares of Otc Healthcare by Subsector 20012004
- Table 15 Reckitt Benckiser Plc Shares of Otc Healthcare by Subsector 20012004
- Table 16 Roche Products Ltd Shares of Otc Healthcare by Subsector 20012004
- Table 17 Seven Seas Ltd Shares of Otc Healthcare by Subsector 20012004
- Table 18 Ssl International Shares of Otc Healthcare by Subsector 20012004
- Table 19 Wyeth Consumer Healthcare Shares of Otc Healthcare by Subsector 20012004
- Table 20 Sales of Otc Healthcare by Distribution Format: % Analysis 1999/2004
- Table 21 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2004
- Table 22 Penetration of Private Label by Sector 20012004
- Table 23 Forecast Sales of Otc Healthcare by Sector: Value 20042009
- Table 24 Forecast Sales of Otc Healthcare by Sector: % Value Growth 20042009
- Table 25 Sales of Analgesics by Subsector: Value 19992004
- Table 26 Sales of Analgesics by Subsector: % Value Growth 19992004
- Table 27 Analgesics Company Shares 20012004
- Table 28 Analgesics Brand Shares 20012004
- Table 29 Forecast Sales of Analgesics by Subsector: Value 20042009
- Table 30 Forecast Sales of Analgesics by Subsector: % Value Growth 20042009
- Table 31 Herbal vs Standard Analgesics 1999/2004